Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Cytometry. Part B, Clinical Cytometry|September 1, 2020
Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristicsDevasis Panda, Gaurav Chatterjee, Rohan Sardana, et al.
Pediatric Blood & Cancer|March 7, 2025
Impact of Invasive Fungal Diseases on Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Insights From a Single-Center StudyAmrutha Narayana Murthy, Shyam Srinivasan, Vasundhara Patil, et al.
Cytometry. Part B, Clinical Cytometry|January 17, 2020
CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemiaPratyusha Gudapati, Twinkle Khanka, Gaurav Chatterjee, et al.
Journal De Mycologie Medicale|November 7, 2024
Prevalence and outcome of candidemia among paediatric cancer patients: A single centre experience from IndiaPoonam Khemani, Shyam Srinivasan, Gaurav Salunke, et al.
JCO Clinical Cancer Informatics|January 21, 2026
PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic LeukemiaSubikksha Saravanan, Raghunathan Rengaswamy, Gaurav Narula, et al.
Psycho-Oncology|August 26, 2021
Psychological distress in primary caregivers of children with cancer during COVID-19 pandemic-A single tertiary care center experienceBadira Cheriyalinkal Parambil, Savita Goswami, Nirmalya Roy Moulik, et al.
Trials|February 1, 2022
Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in IndiaNandana Das, Shripad Banavali, Sameer Bakhshi, et al.
Indian Journal of Cancer|August 8, 2018
Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial HospitalGaurav Narula, Maya Prasad, Shalini Jatia, et al.
Cytometry. Part B, Clinical Cytometry|October 9, 2016
Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000Prashant R Tembhare, Sitaram Ghogale, Nisha Ghatwai, et al.
Pediatric Blood & Cancer|November 19, 2022
Pediatric cancer-associated thrombosis: Analysis from a tertiary care cancer center in IndiaNidhi Dhariwal, Venkata Rama Mohan Gollamudi, K P Sangeetha, et al.
Pageof 8